Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
2021 · Advanced Drug Delivery Reviews · 72 citations
https://doi.org/10.1016/j.addr.2021.03.015
M
Miriam Alb
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
478
Citations
9
h-index
9
i10-index
Miriam Alb is an academic researcher from University of Würzburg. The author has contributed to research in topics: CAR-T cell therapy research & Viral Infectious Diseases and Gene Expression in Insects & Immunotherapy and Immune Responses. The author has an h-index of 9, co-authored 25 publications.
ORCID: 0000-0001-6454-9906Papers by this author
worksBreast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells
2024 · Cell stem cell · 70 citations
https://doi.org/10.1016/j.stem.2024.04.018
Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma
2012 · Cancer Immunology Immunotherapy · 14 citations
https://doi.org/10.1007/s00262-012-1290-9
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma
2025 · Molecular Therapy · 1 citations
https://doi.org/10.1016/j.ymthe.2025.10.046
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma
2025 · Cancer Cell · 1 citations
https://doi.org/10.1016/j.ccell.2025.10.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat